Alkem Labs Bets on Cardiac Devices with Majority Stake in Occlutech
Strategic Acquisition Announcement Alkem Laboratories has moved to deepen its presence in medical technology through a binding offer by its devices arm to acquire a controlling stake in Occlutech Holding AG. The proposed transaction involves purchasing up to 55% of the Swiss cardiovascular device manufacturer for roughly $118 million, valuing the company at around €180 million. The deal,…



